Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2008) 16 P192

Diabetes and cardiovascular diseases

Endothelin-1 is correlated with TGF-β1 but not with glycemic control in normotensive subjects with type 2 diabetes

Serkan Yener1, Pinar Akan2, Abdurrahman Comlekci1, Baris Akinci1, Firat Bayraktar1 & Sena Yesil1

1Division of Endocrinology and Metabolism, School of Medicine, Dokuz Eylul University, Izmir, Turkey; 2Department of Biochemistry, School of Medicine, Dokuz Eylul University, Izmir, Turkey.

Objectives: Endothelial dysfunction contributes to the development of atherosclerosis in diabetic subjects. Endothelin-1 (ET-1) is an endothelium derived vasoconstrictor. It has been shown that ET-1 levels are increased in a variety of situations such as diabetes, hypertension and obesity. Transforming growth factor beta1 (TGF-β1) is an important cytokine for the development of renal injury in type 2 diabetic patients and associated with hyperglycemia and insulin resistance. Cell culture studies showed that TGF-β may upregulate ET-1 production. Our aim was to demonstrate the possible relations between ET-1 and TGF-β1 in type 2 diabetic patients.

Methods: Forty Type 2 diabetic subjects without any micro or macrovascular diabetic complications, hypertension or microalbuminuria were enrolled. The patients were being treated with glimepride for at least 12 weeks. Patients treated with other oral antidiabetics or insulin, anti-hypertensive drugs, anticoagulants or anti-obesity drugs were not included.

Results: The mean values were; A1c: 7.8%, fasting plasma glucose: 167.9 mg/dl, BMI: 27.5 kg/m2, waist circumference: 91.0 cm, TGF-β1: 29.68 ng/ml and ET-1: 0.33 fmol/ml. ET-1 levels were not associated with glycemic parameters or anthropometric features. ET-1 levels did not differ between males and females. ET-1 levels were found to be correlated with TGF-β1 levels (r=0.358 P<0.05).

Conclusion: Our results demonstrate that ET-1 expression is associated with TGF-β1 in type 2 diabetic people. Neither glycemic parameters nor anthropometric features were found to effect ET-1 levels in type 2 diabetic people without diabetes related complications. A possible explanation for this finding may be the strict enrolment criteria for the study. Because of the inclusion of patients without diabetes related complications, ET-1 levels might be found to be unrelated with glycemic parameters.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

No recent abstracts.